MSB 3.06% $1.01 mesoblast limited

Ann: DREAM HF Trial Published in JACC, page-37

  1. 2,661 Posts.
    lightbulb Created with Sketch. 160


    The CNN article suggests "in conjunction with heart failure drugs" . Big pharma may see this as a positive for the approval Stem cells as revenue for drugs continue! Just sayin, and fellow posters have mentioned this previously as well.

    More than 6 million adults in the United States have chronic heart failure, and most are treated with drugs that address the symptoms of the condition. The patients included in the new study were all taking medications for heart failure, and the new research suggests that cell therapy can be beneficial when used in conjunction with heart failure drugs.
    Last edited by hotcopinvestor: 28/02/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.030(3.06%)
Mkt cap ! $1.153B
Open High Low Value Volume
$1.01 $1.04 99.0¢ $5.111M 5.050M

Buyers (Bids)

No. Vol. Price($)
2 211966 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 136540 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.